RU2019133777A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2019133777A3 RU2019133777A3 RU2019133777A RU2019133777A RU2019133777A3 RU 2019133777 A3 RU2019133777 A3 RU 2019133777A3 RU 2019133777 A RU2019133777 A RU 2019133777A RU 2019133777 A RU2019133777 A RU 2019133777A RU 2019133777 A3 RU2019133777 A3 RU 2019133777A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17165082.3 | 2017-04-05 | ||
| EP17165082 | 2017-04-05 | ||
| PCT/EP2018/058522 WO2018185120A1 (en) | 2017-04-05 | 2018-04-04 | Heteroaromatic compounds useful in therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2019133777A3 true RU2019133777A3 (https=) | 2021-04-23 |
| RU2019133777A RU2019133777A (ru) | 2021-04-23 |
| RU2770363C2 RU2770363C2 (ru) | 2022-04-15 |
Family
ID=58489645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2019133777A RU2770363C2 (ru) | 2017-04-05 | 2018-04-04 | Гетероароматические соединения, пригодные в терапии |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11001587B2 (https=) |
| EP (1) | EP3606926B1 (https=) |
| JP (1) | JP7200126B2 (https=) |
| CN (1) | CN110520424B (https=) |
| AU (1) | AU2018248581B2 (https=) |
| CA (1) | CA3057408A1 (https=) |
| DK (1) | DK3606926T3 (https=) |
| ES (1) | ES2880327T3 (https=) |
| NZ (1) | NZ758449A (https=) |
| PL (1) | PL3606926T3 (https=) |
| RU (1) | RU2770363C2 (https=) |
| WO (1) | WO2018185120A1 (https=) |
| ZA (1) | ZA201907303B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017147526A1 (en) | 2016-02-26 | 2017-08-31 | The Board Of Trustees Of The Leland Stanford Junior University | Pi-kinase inhibitors with anti-infective activity |
| DK3606926T3 (da) * | 2017-04-05 | 2021-07-05 | Curovir Ab | Heteroaromatiske forbindelser anvendelige i terapi |
| WO2020074160A1 (en) | 2018-10-10 | 2020-04-16 | Curovir Ab | Condensed pyrimidine or pyridazine derivatives as antiviral agents |
| CA3115128A1 (en) | 2018-10-10 | 2020-04-16 | Curovir Ab | 2,6-dimethyl-n-((pyridin-4-yl)methyl)imidazo[1,2-b]pyridazin-8-amine and 2,5-dimethyl-n-[(pyridin-4-yl)methyl]pyrazolo[1,5-a]pyrimidin-7-amine derivatives for treating viral infections |
| CA3126143A1 (en) * | 2019-01-11 | 2020-07-16 | The Board Of Trustees Of The Leland Stanford Junior University | Pi4-kinase inhibitors with anti-cancer activity |
| KR20220035322A (ko) | 2019-03-21 | 2022-03-22 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | Pi4-키나아제 억제제 및 이의 사용 방법 |
| EP4028131B1 (en) | 2019-08-20 | 2023-11-22 | Curovir Ab | Heteroaromatic compounds useful in therapy |
| EP4676485A1 (en) | 2023-03-09 | 2026-01-14 | Curovir Ab | Compound and formulation for systemic therapy by oral transmucosal administration |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6313124B1 (en) | 1997-07-23 | 2001-11-06 | Dupont Pharmaceuticals Company | Tetrazine bicyclic compounds |
| US6191131B1 (en) * | 1997-07-23 | 2001-02-20 | Dupont Pharmaceuticals Company | Azolo triazines and pyrimidines |
| JP2003510325A (ja) * | 1999-09-30 | 2003-03-18 | ニューロジェン・コーポレーション | ある種のアルキレンジアミン−置換ピラゾロ［１，５−ａ］−１，５−ピリミジン及びピラゾロ［１，５−ａ］−１，３，５−トリアジン |
| RU2340611C2 (ru) * | 2000-09-15 | 2008-12-10 | Вертекс Фармасьютикалз Инкорпорейтед | Производные пиразола, используемые в качестве ингибиторов протеинкиназы |
| US20070078136A1 (en) | 2005-09-22 | 2007-04-05 | Bristol-Myers Squibb Company | Fused heterocyclic compounds useful as kinase modulators |
| WO2010086040A1 (en) | 2009-01-29 | 2010-08-05 | Biomarin Iga, Ltd. | Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy |
| FR2943058B1 (fr) | 2009-03-11 | 2011-06-03 | Centre Nat Rech Scient | Derives de pyrazolo°1,5-a!-1,3,5-triazines, leur preparation et leur application en therapeutique. |
| HRP20190128T1 (hr) * | 2011-05-04 | 2019-03-08 | Rhizen Pharmaceuticals S.A. | Novi spojevi kao modulatori protein kinaza |
| EP2634189A1 (en) | 2012-03-01 | 2013-09-04 | Lead Discovery Center GmbH | Pyrazolo-triazine derivatives as selective cyclin-dependent kinase inhibitors |
| RU2689788C2 (ru) * | 2014-01-22 | 2019-05-29 | Куровир Аб | ПИРАЗОЛО[1,5-а]ПИРИМИДИНЫ В КАЧЕСТВЕ ПРОТИВОВИРУСНЫХ СОЕДИНЕНИЙ |
| WO2015140491A1 (en) * | 2014-03-18 | 2015-09-24 | Micromass Uk Limited | Liquid extraction matrix assisted laser desorption ionisation ion source |
| CN107949563B (zh) | 2015-06-24 | 2020-06-05 | 库洛维公司 | 治疗中有用的吡唑并[1,5-a]三嗪-4-胺衍生物 |
| DK3606926T3 (da) * | 2017-04-05 | 2021-07-05 | Curovir Ab | Heteroaromatiske forbindelser anvendelige i terapi |
-
2018
- 2018-04-04 DK DK18716212.8T patent/DK3606926T3/da active
- 2018-04-04 ES ES18716212T patent/ES2880327T3/es active Active
- 2018-04-04 WO PCT/EP2018/058522 patent/WO2018185120A1/en not_active Ceased
- 2018-04-04 AU AU2018248581A patent/AU2018248581B2/en active Active
- 2018-04-04 US US16/495,903 patent/US11001587B2/en active Active
- 2018-04-04 RU RU2019133777A patent/RU2770363C2/ru not_active Application Discontinuation
- 2018-04-04 NZ NZ758449A patent/NZ758449A/en unknown
- 2018-04-04 EP EP18716212.8A patent/EP3606926B1/en active Active
- 2018-04-04 JP JP2019554725A patent/JP7200126B2/ja active Active
- 2018-04-04 PL PL18716212T patent/PL3606926T3/pl unknown
- 2018-04-04 CA CA3057408A patent/CA3057408A1/en active Pending
- 2018-04-04 CN CN201880023679.2A patent/CN110520424B/zh active Active
-
2019
- 2019-11-04 ZA ZA2019/07303A patent/ZA201907303B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2880327T3 (es) | 2021-11-24 |
| EP3606926B1 (en) | 2021-05-26 |
| CN110520424B (zh) | 2022-06-21 |
| BR112019019796A2 (pt) | 2020-04-22 |
| EP3606926A1 (en) | 2020-02-12 |
| ZA201907303B (en) | 2022-07-27 |
| RU2770363C2 (ru) | 2022-04-15 |
| PL3606926T3 (pl) | 2021-11-02 |
| US20200031833A1 (en) | 2020-01-30 |
| JP7200126B2 (ja) | 2023-01-06 |
| AU2018248581A1 (en) | 2019-11-07 |
| JP2020516599A (ja) | 2020-06-11 |
| DK3606926T3 (da) | 2021-07-05 |
| AU2018248581B2 (en) | 2022-05-26 |
| US11001587B2 (en) | 2021-05-11 |
| RU2019133777A (ru) | 2021-04-23 |
| CA3057408A1 (en) | 2018-10-11 |
| NZ758449A (en) | 2026-03-27 |
| CN110520424A (zh) | 2019-11-29 |
| WO2018185120A1 (en) | 2018-10-11 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20220112 |
|
| FZ9A | Application not withdrawn (correction of the notice of withdrawal) |
Effective date: 20220112 |